Paper‑based batch records, manual equipment integration, limited production visibility, and inconsistent quality documentation caused compliance risks and 20% batch rejection rate.
Implemented pharmaceutical MES with automated batch execution, real‑time equipment monitoring, electronic batch records, statistical process control, and 21 CFR Part 11 compliance.
- Batch rejection rate reduced from 20% to 2%
- Production cycle time decreased 25%
- $6M annual savings with 99.7% first‑pass quality rate
Validates MES as critical infrastructure for pharma quality, compliance, and operational efficiency in regulated manufacturing.
- Zero FDA 483 observations in post‑implementation inspection
- Real‑time OEE monitoring across 8 production lines
- Paperless operations with full electronic signatures
